Die Grünenthal Gruppe

Our Annual Report is fresh off the press! Grünenthal's people have transformed our company over the last few years, uniquely positioning us to meet the increased demand for better pain treatments. 🌎 Our medicines today help more patients than ever before as we are growing our footprint in key pharmaceutical markets, especially in the United States 🧬 We advanced key R&D projects, creating one of the strongest pain-focused pipelines in the industry 📦 We ensured uninterrupted supply of medicines to patients in over 100 countries 💊 Through strategic acquisitions, we expanded our portfolio of established medicines This momentum put us in an excellent position to deliver outstanding business performance.  Read more about our story of transformation in our Annual Report: https://bit.ly/3UklN84 #WeAreGrünenthal #WorldFreeofPain

Another top ESG rating for Grünenthal! We are recognized among the industry’s top performers in our latest independent ESG rating by Morningstar Sustainalytics. With our best-ever Risk Management Score, we continue to demonstrate strong management of environmental, social, and governance risks – four years in a row! Grünenthal was also attributed a low ESG risk. A huge thank you to our employees for their dedication to sustainability and responsible business practices. This achievement is yours! Read more: https://bit.ly/4kG6SQP #ESG #Sustainability #WeAreGrünenthal

Joukje Oosterman won the EFIC-Grünenthal-Grant (E-G-G) for pain research in 2016 and it enabled her to investigate fresh areas of research that are still advancing her career in pain science today. It is now 20 years since the E-G-G started funding pain research for early-career scientists. One of those innovators, Joukje Oosterman, recently gave a short interview to explain how the insights from her winning project are still opening up fresh research opportunities – eight years later! 🔬The E-G-G provided funding for Joukje to explore a new line of research. 📑She recently published a paper that directly leverages findings from that research. 🤝And recognition from the E-G-G helped Joukje connect with the pain science community. Now, Joukje is a full-time professor who leads the Neuropsychology and Rehabilitation Psychology department at Radboud University. Want to know more about her career path and the impact of winning the E-G-G? Follow the link in the comments to read her story!   #EFIC-Grünenthal-Grant #WorldFreeofPain #WeAreGrünenthal

We are looking for the new Global Graduates starting in July 2025! If you are about to graduate or have recently completed your studies, our Global Graduate Programme is your opportunity to kickstart your career.  Whether you already have a clear vision of your dream job or want to explore various professional paths, this programme is designed to set you up for success.  Over 24 months, you will rotate through different functions and work on impactful projects that provide top management visibility. Throughout this experience, you will build valuable skills and expand your network to shape your future career.👌 Do you need more motivation? Listen to Shivani and Can share why you should apply to become the next Global Graduate at Grünenthal! #WeAreGrünenthal

Meet our trio of winning pain scientists! Nearly €2 million of funding has empowered around 75 pioneering pain research projects since the EFIC-Grünenthal-Grant (E-G-G) was set up in 2004. Now, we are delighted to announce the next three early-career scientists who have successfully won support from the E-G-G in 2025! Franziska Karl-Schöller will examine potential lab-grown skin models for researching postherpetic neuralgia. Ama Kissi will investigate how racialised stereotypes influence the information that healthcare providers seek when diagnosing children. Maddalena Comini will explore opportunities to treat neuropathic pain by creating personalised medicines based on ribonucleic acids (RNAs). #EFIC-Grünenthal-Grant #WorldFreeofPain #WeAreGrünenthal #Innovation #Research #Science

Women belong everywhere – leading, innovating and shaping the future. International Women’s Day is a moment to celebrate their achievements and, more importantly, to act in building a more inclusive and equitable world. At Grünenthal, we are committed to supporting women’s growth by providing opportunities at every career stage, strengthening allyship and celebrating women in leadership. With 42% of our managers being women, we are proud of our progress, but we know there is always more to do. Empowering women is not just a one-day effort – it is something we focus on all year. But this month, we are putting an extra spotlight on the conversations and initiatives that help drive progress. By continuing to support each other, we contribute to a workplace where women can develop, grow and reach their goals. #WeAreGrünenthal #IWD2025

We wish everyone observing Ramadan a time of reflection and joy. May this month strengthen the bonds of community and connection. #WeAreGrünenthal

We have entered into a licensing agreement to bring Qutenza, a topical, non-systemic, non-opioid pain patch, to patients in Canada.  Searchlight Pharma, the specialty pharma division of Apotex Inc., will pursue marketing authorization and, upon regulatory approval, market and distribute Qutenza in Canada, one of the largest pharmaceutical markets in the world. #Licensing #BusinessDevelopment #WorldFreeofPain

Rafael Joaquin Lopez Ruis takes a highly personal approach to his role as a sales representative at Grünenthal España. And Joaquín has a 25-year track record of providing valuable support for healthcare professionals – and finding the best way to help patients who depend on innovative pain medications. Interested in more info about Joaquín’s deep commitment to making life better for pain patients? Click the link in the comments below! #WorldFreeofPain #WeAreGrünenthal #100reasons

Today, we mark the 10th anniversary of the International Day of Women and Girls in Science, celebrating the progress we’ve made and acknowledging what’s yet to be achieved to close the gender gap in science. Our colleague Dalena was enthusiastic about science from a young age, asking for her first chemistry set at age seven and being fascinated by science ever since. Today, she leads the way as ‘Head of Regulatory Affairs’ at our US affiliate Averitas Pharma. Follow the link in the comments to listen to her story.   #IDWGS #WomenInScience #GirlsInSTEM #WeAreGrünenthal